2.1.1.1 Key data from secondary sources 25 2.1.2 PRIMARY DATA 26 2.1.2.1 Key data from primary sources 26 2.1.2.2 Key industry insights 27 2.2 MARKET SIZE ESTIMATION 27 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29 2.4 MARKET SHARE ESTIMATION 30 2.5 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31 4 PREMIUM INSIGHTS 40 4.1 IN VITRO DIAGNOSTICS ( IVD ): MARKET OVERVIEW 40 4.2 ASIA-PACIFIC : IN VITRO DIAGNOSTICS MARKET , BY PRODUCTS & SERVICES 41 4.3 GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET 42 4.4 GEOGRAPHIC MIX : IN VITRO DIAGNOSTICS MARKET 43 4.5 IN VITRO DIAGNOSTICS MARKET : DEVELOPING VS . DEVELOPED MARKETS 44
5 MARKET OVERVIEW 45 5.1 INTRODUCTION 46 5.2 MARKET DYNAMICS 47 5.2.1 MARKET DRIVERS 48 5.2.1.1 Rising incidence of chronic lifestyle diseases 48 5.2.1.2 Increasing adoption of point-of-care testing 50 5.2.1.3 Growing awareness of personalized medicine 50 5.2.1.4 Growth in the number of private diagnostic centers 51 5.2.2 MARKET RESTRAINTS 52 5.2.2.1 Inadequate reimbursement 52 5.2.2.2 Rising healthcare costs and low budgets 52 5.2.3 MARKET OPPORTUNITIES 53 5.2.3.1 Introduction of a new range of condition-specific markers and tests with advances in genomics and proteomics 53 5.2.3.2 Emerging economies with increasing investments 53 5.2.3.3 Growing significance of companion diagnostics 54 5.2.4 MARKET CHALLENGES 54
Contact :
Ann
Sales Manager
Market Research Report Store
Tel : + 00-1-626-3463946 - U . S